Articles dans des revues avec comité de lecture (79)
  1. 32. Finkel, R. S., Mercuri, E., Darras, B. T., Connolly, A. M., Kuntz, N. L., Kirschner, J., Chiriboga, C. A., Saito, K., Deconinck, N., Tizzano, E., Topaloglu, H., Tulinius, M., Montes, J., Glanzman, A. M., Bishop, K., Zhong, Z. J., Gheuens, S., Bennett, C. F., Schneider, E., Farwell, W., De Vivo, D. C., & ENDEAR Study Group, (2017). Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. The New England journal of medicine, 377(18), 1723-1732. doi:10.1056/NEJMoa1702752
  2. 33. Guisset, F., Ferreiro, C., Voets, S., Sellier, J., Debaugnies, F., Corazza, F., Deconinck, N., & Prigogine, C. (2016). Anti-GQ1b antibody syndrome presenting as acute isolated bilateral ophthalmoplegia: Report on two patients and review of the literature. European journal of paediatric neurology, 20(3), 439-443. doi:10.1016/j.ejpn.2016.02.002
  3. 34. Coppens, S., Koralkova, P., Aeby, A., Mojzikova, R., Deconinck, N., Kadhim, H., & van Wijk, R. (2016). Recurrent episodes of myoglobinuria, mental retardation and seizures but no hemolysis in two brothers with phosphoglycerate kinase deficiency. Neuromuscular disorders, 26(3), 207-210. doi:10.1016/j.nmd.2015.11.008
  4. 35. Baijot, S., Colin, C., Slama, H., Söderlund, G., Dan, B., & Deconinck, N. (2016). Neuropsychological and neurophysiological benefits from white noise in children with and without ADHD. Behavioral and brain functions, 12(11), 1-13. doi:10.1186/s12993-016-0095-y
  5. 36. Ricotti, V., Mandy, W. P. L., Scoto, M., Pane, M., Deconinck, N., Messina, S., Mercuri, E., Skuse, D. D., & Muntoni, F. (2016). Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations. Developmental medicine and child neurology, 58(1), 77-84. doi:10.1111/dmcn.12922
  6. 37. Deconinck, N., Richard, P., Allamand, V., Behin, A., Lafôret, P., Ferreiro, A., de Becdelievre, A., Ledeuil, C., Gartioux, C., Nelson, I., Carlier, R. Y., Carlier, P., Wahbi, K., Romero, N., Zabot, M. T., Bouhour, F., Tiffreau, V., Lacour, A., Eymard, B., & Stojkovic, T. (2015). Bethlem myopathy: long-term follow-up identifies COL6 mutations predicting severe clinical evolution. Journal of neurology, neurosurgery and psychiatry, 86(12), 1337-1346. doi:10.1136/jnnp-2013-307245
  7. 38. Seferian, A. M., Moraux, A., Annoussamy, M., Canal, A., Decostre, V., Diebate, O., Le Moing, A.-G., Gidaro, T., Deconinck, N., Van Parys, F., Vereecke, W., Wittevrongel, S., Mayer, M., Maincent, K., Desguerre, I., Thémar-Noel, C., Cuisset, J. M., Tiffreau, V., Denis, S., Jousten, V., Quijano-Roy, S., Voit, T., Hogrel, J.-Y., & Servais, L. (2015). Upper limb strength and function changes during a one-year follow-up in non-ambulant patients with Duchenne Muscular Dystrophy: an observational multicenter trial. PloS one, 10(2), e0113999. doi:10.1371/journal.pone.0113999
  8. 39. Seferian, A. M., Moraux, A., Canal, A., Decostre, V., Diebate, O., Le Moing, A.-G., Gidaro, T., Deconinck, N., Van Parys, F., Vereecke, W., Wittevrongel, S., Annoussamy, M., Mayer, M., Maincent, K., Cuisset, J. M., Tiffreau, V., Denis, S., Jousten, V., Quijano-Roy, S., Voit, T., Hogrel, J.-Y., & Servais, L. (2015). Upper limb evaluation and one-year follow up of non-ambulant patients with spinal muscular atrophy: an observational multicenter trial. PloS one, 10(4), e0121799. doi:10.1371/journal.pone.0121799
  9. 40. Kissine, M., Cano-Chervel, J., Carlier, S., De Brabanter, P., Ducenne, L., Pairon, M.-C., Deconinck, N., Delvenne, V., & Leybaert, J. (2015). Children with Autism Understand Indirect Speech Acts: Evidence from a Semi-Structured Act-Out Task. PloS one, 10(11), e0142191. doi:10.1371/journal.pone.0142191
  10. 41. Baijot, S., Deliens, G., Camara Lopez, M., Schmitz, R., Slama, H., Deconinck, N., & Colin, C. (2015). Profil neuropsychologique positivement sensible au bruit blanc : évaluation des fonctions cognitives dans une classe virtuelle. L'Encéphale, 41, 187.
  11. 42. Voit, T., Topaloglu, H., Straub, V., Muntoni, F., Deconinck, N., Campion, G., De Kimpe, S. J., Eagle, M., Guglieri, M., Hood, S., Liefaard, L., Lourbakos, A., Morgan, A., Nakielny, J., Quarcoo, N., Ricotti, V., Rolfe, K., Servais, L., Wardell, C., Wilson, R., Wright, P., & Kraus, J. E. (2014). Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study. Lancet neurology, 13(10), 987-996. doi:10.1016/S1474-4422(14)70195-4
  12. 43. Van Schil, K., Meire, F., Karlstetter, M., Bauwens, M., Verdin, H., Coppieters, F., Scheiffert, E., Van Nechel, C., Langmann, T., Deconinck, N., & De Baere, E. (2014). Early-onset autosomal recessive cerebellar ataxia associated with retinal dystrophy: new human hotfoot phenotype caused by homozygous GRID2 deletion. Genetics in medicine. doi:10.1038/gim.2014.95
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>